porcin
reproduct
respiratori
syndrom
viru
prrsv
porcin
epidem
diarrhea
viru
pedv
porcin
nidovirus
repres
emerg
viral
pathogen
caus
heavi
econom
impact
swine
industri
although
ribavirin
wellknown
antivir
drug
broad
rang
dna
rna
virus
vitro
inhibitori
effect
mechan
action
porcin
nidoviru
replic
remain
elucid
therefor
present
studi
conduct
determin
whether
ribavirin
suppress
porcin
nidoviru
infect
result
demonstr
ribavirin
treatment
dosedepend
inhibit
replic
nidovirus
antivir
activ
ribavirin
porcin
nidoviru
replic
found
primarili
exert
earli
time
postinfect
treatment
ribavirin
result
mark
reduct
viral
genom
subgenom
rna
synthesi
viral
protein
express
progeni
viru
product
dosedepend
manner
investig
mechan
action
ribavirin
prrsv
pedv
reveal
addit
guanosin
ribavirin
treatment
significantli
revers
antivir
effect
suggest
deplet
intracellular
gtp
pool
inhibit
imp
dehydrogenas
may
essenti
ribavirin
activ
sequenc
analysi
show
mutat
frequenc
ribavirintr
cell
similar
untreat
cell
indic
ribavirin
induc
errorpron
replic
taken
togeth
data
indic
ribavirin
might
good
therapeut
agent
porcin
nidoviru
also
potenti
candid
evalu
human
anim
coronavirus
nidoviral
order
envelop
singlestrand
positivesens
rna
virus
anim
host
includ
famili
arterivirida
coronavirida
ronivirida
cavanagh
mayo
spaan
et
al
despit
strike
differ
genom
size
virion
morpholog
genom
organ
express
strategi
two
group
belong
nidoviral
order
found
compar
nidoviru
genom
contain
two
larg
orf
compris
twothird
viral
genom
encod
nonstructur
protein
nsp
remain
orf
locat
termin
region
code
structur
protein
lai
et
al
snijder
spaan
initi
translat
yield
lab
replicas
polyprotein
respect
proteolyt
process
function
nsp
includ
viral
rnadepend
rna
polymeras
rdrp
bautista
et
al
van
aken
et
al
ziebuhr
et
al
rdrpcontain
replic
complex
mediat
genom
rna
replic
subgenom
sg
mrna
transcript
eventu
gener
nest
set
cotermin
sg
mrna
individu
translat
structur
protein
lai
et
al
snijder
spaan
porcin
reproduct
respiratori
syndrom
viru
prrsv
pathogen
macrophagetrop
arteriviru
pig
etiolog
agent
acut
respiratori
ill
young
piglet
reproduct
failur
pregnant
sow
albina
prrsv
primarili
replic
porcin
alveolar
macrophag
pam
establish
persist
infect
lymphoid
tissu
infect
pig
last
sever
month
albina
et
al
christopherhen
et
al
duan
et
al
will
et
al
result
prrsv
infect
result
suppress
normal
macrophag
function
immun
respons
may
render
pig
suscept
secondari
bacteri
viral
infect
lead
sever
diseas
either
agent
alon
allan
et
al
feng
et
al
harm
et
al
will
et
al
porcin
epidem
diarrhea
viru
pedv
pathogen
enterocytetrop
coronaviru
swine
etiolog
agent
acut
enter
character
lethal
wateri
diarrhea
follow
dehydr
lead
death
high
mortal
rate
suckl
piglet
debouck
pensaert
two
virus
prrsv
pedv
devast
porcin
nidovir
pathogen
still
continu
plagu
swineproduc
nation
caus
tremend
econom
loss
global
asian
pork
industri
neumann
et
al
pensaert
yeo
ribavirin
also
known
virazol
synthet
guanosin
analog
exhibit
broadspectrum
antivir
activ
vitro
sidwel
et
al
use
experiment
wide
rang
dna
rna
virus
includ
gb
viru
b
hantaan
viru
hendra
viru
respiratori
syncyti
viru
lassa
fever
viru
norwalk
viru
west
nile
viru
chang
georg
cooper
et
al
day
et
al
mccormick
et
al
lanford
et
al
rockx
et
al
severson
et
al
notabl
ribavirin
use
combin
treatment
chronic
hepat
c
viru
hcv
infect
cum
et
al
davi
et
al
howev
still
report
regard
antivir
effect
ribavirin
replic
cycl
porcin
nidovirus
present
studi
therefor
tri
investig
antivir
activ
ribavirin
mechan
action
target
cell
upon
porcin
nidoviru
infect
independ
treatment
target
cell
ribavirin
significantli
impair
prrsv
pedv
infect
experi
reveal
suppress
ribavirin
affect
postentri
step
replic
cycl
prrsv
pedv
includ
viral
genom
sg
rna
synthesi
viral
protein
express
viru
product
addit
guanosin
ribavirin
treatment
result
moder
revers
antivir
effect
suggest
ribavirin
activ
involv
depress
cellular
guanosin
triphosph
gtp
level
sequenc
analysi
prrsv
pedv
genom
ribavirintr
nontreat
group
reveal
mutat
rate
similar
indic
ribavirin
induc
catastroph
mutat
replic
porcin
nidovirus
altogeth
result
suggest
ribavirin
may
excel
therapeut
option
nidoviru
infect
human
veterinari
subject
cell
cultur
rpmi
medium
invitrogen
carlsbad
ca
supplement
fetal
bovin
serum
fb
invitrogen
antibioticantimycot
solut
invitrogen
mm
hepe
invitrogen
mm
sodium
pyruv
invitrogen
nonessenti
amino
acid
invitrogen
presenc
gml
zeocin
invitrogen
vero
cell
cultur
alpha
minimum
essenti
medium
invitrogen
fb
antibioticantimycot
solut
cell
maintain
c
humidifi
co
incub
prrsv
strain
propag
cell
describ
previous
pedv
strain
kindli
provid
korean
anim
plant
fisheri
quarantin
inspect
agenc
propag
vero
cell
describ
previous
hofmann
wyler
ribavirin
mycophenol
acid
mpa
purchas
sigma
st
loui
mo
dissolv
distil
water
dw
dimethyl
sulfoxid
dmso
respect
monoclon
antibodi
mab
prrsv
n
protein
purchas
rural
technolog
brook
sd
pedv
spike
glycoproteinspecif
n
proteinspecif
monoclon
antibodi
mab
kind
gift
sanggeon
yeo
kyungpook
nation
univers
daegu
south
korea
antibodi
horseradish
peroxidas
hrp
conjug
secondari
antibodi
purchas
santa
cruz
biotechnolog
santa
cruz
ca
cytotox
effect
reagent
vero
cell
analyz
bromid
mtt
assay
sigma
detect
cell
viabil
briefli
vero
cell
grown
cellswel
tissu
cultur
plate
ribavirin
mpa
treatment
h
one
day
incub
l
mtt
solut
mgml
ad
well
sampl
incub
addit
h
supernat
remov
well
l
dmso
ad
dissolv
color
formazan
crystal
produc
mtt
absorb
solut
measur
nm
use
enzymelink
immunosorb
assay
plate
reader
mtt
assay
perform
triplic
vero
cell
grown
microscop
coverslip
place
tissu
cultur
plate
pretreat
ribavirin
mpa
h
mock
infect
infect
prrsv
pedv
multipl
infect
moi
respect
virusinfect
cell
grown
presenc
ribavirin
hpi
fix
paraformaldehyd
min
room
temperatur
rt
permeabil
triton
pb
rt
min
cell
block
bovin
serum
albumin
bsa
pb
min
rt
incub
nspecif
mab
h
wash
five
time
pb
cell
incub
h
rt
goat
antimous
secondari
antibodi
conjug
alexa
fluor
molecular
probe
carlsbad
ca
follow
counterstain
dapi
sigma
coverslip
mount
microscop
glass
slide
mount
buffer
glycerol
sodium
azid
pb
cell
stain
visual
use
fluoresc
leica
dm
il
led
microscop
leica
wetzlar
germani
vero
cell
grown
tissu
cultur
plate
day
mock
infect
infect
prrsv
pedv
moi
indic
time
cell
harvest
l
lysi
buffer
mm
mm
nitro
phenyl
phosphat
mm
mop
mm
mgcl
mm
nacl
mm
egta
ph
mm
sodium
orthovanad
gml
gml
aprotinin
gml
leupeptin
mm
pmsf
sonic
ice
five
time
homogen
lyse
min
ice
clarifi
centrifug
g
eppendorf
centrifug
hamburg
germani
min
c
protein
concentr
cell
lysat
determin
bca
protein
assay
pierc
rockford
il
cell
lysat
mix
nupag
sampl
buffer
invitrogen
boil
c
min
protein
separ
nupag
gradient
bistri
gel
invitrogen
reduc
condit
electrotransf
onto
immunobilonp
millipor
billerica
membran
subsequ
block
powder
skim
milk
bd
bioscienc
belford
tb
mm
trishcl
ph
mm
nacl
tbst
c
h
react
c
overnight
primari
antibodi
prrsv
n
pedv
blot
incub
secondari
horseradish
peroxidas
hrp
label
antibodi
santa
cruz
biotechnolog
dilut
h
c
protein
visual
enhanc
chemiluminesc
ecl
reagent
amersham
bioscienc
piscataway
nj
accord
manufactur
instruct
quantifi
viral
protein
product
band
densiti
prrsv
n
pedv
protein
quantit
analyz
use
comput
densitomet
wright
cell
imag
facil
wcif
version
imagej
softwar
packag
http
wwwuhnresearchcafacilitieswcifimagej
base
densiti
valu
rel
gene
vero
cell
infect
prrsv
pedv
respect
moi
describ
hpi
ribavirin
ad
give
indic
final
concentr
remaind
time
cours
experi
virusinfect
ribavirintr
cell
maintain
infect
termin
hpi
fix
monolay
paraformaldehyd
min
rt
fix
cell
subject
ifa
assess
presenc
prrsv
pedv
infect
describ
intern
assay
perform
describ
previous
cai
et
al
briefli
vero
cell
grown
cultur
plate
infect
prrsv
pedv
respect
moi
c
h
respect
unbound
virus
wash
pb
cell
either
incub
c
c
presenc
ribavirin
h
follow
treatment
proteas
k
mgml
c
min
remov
bound
unintern
viru
particl
prrsvinfect
cell
serial
dilut
rpmi
ad
onto
fresh
cell
monolay
tissu
cultur
plate
h
postincub
intern
virus
titrat
ifa
describ
tissu
cultur
infecti
dose
tcid
calcul
pedv
serial
dilut
infect
cell
ad
onto
uninfect
vero
cell
h
intern
virus
titrat
use
plaqu
assay
describ
previous
plaqu
count
crystal
violet
stain
vero
cell
incub
ribavirin
h
prior
infect
inocul
prrsv
pedv
moi
h
c
viru
inoculum
subsequ
remov
infect
cell
maintain
fresh
medium
contain
ribavirin
h
total
rna
extract
lysat
infect
cell
hpi
use
trizol
reagent
invitrogen
treat
dnase
takara
accord
manufactur
protocol
concentr
extract
rna
measur
use
nanovu
spectrophotomet
ge
healthcar
piscataway
nj
quantit
realtim
rtpcr
conduct
use
thermal
cycler
dice
real
time
system
takara
genespecif
primer
set
tabl
describ
previous
sagong
lee
rna
level
viral
gene
normal
mrna
dehydrogenas
gapdh
gene
rel
quantiti
rq
mrna
accumul
evalu
use
ct
method
detect
alter
genom
rna
sg
mrna
level
presenc
ribavirin
porcin
nidoviru
infect
result
obtain
use
ribavirintr
sampl
compar
vehicletr
result
vero
cell
prrsv
pedv
infect
treatment
ribavirin
describ
cultur
supernat
collect
differ
time
point
hpi
store
c
titer
prrsv
measur
limit
dilut
cell
ifa
describ
quantifi
tcid
per
ml
pedv
titer
determin
plaqu
assay
use
vero
cell
quantifi
plaqueform
unit
pfu
per
ml
vero
cell
preincub
guanosin
h
ribavirin
ad
medium
variou
final
concentr
inocul
prrsv
pedv
describ
viru
inoculum
remov
infect
cell
maintain
fresh
medium
contain
ribavirin
guanosin
h
dpi
virusinfect
cell
fix
subject
ifa
evalu
presenc
prrsv
pedv
infect
describ
n
gene
code
region
prrsv
pedv
sequenc
monitor
mutat
frequenc
cell
prrsv
pedv
infect
treat
ribavirin
describ
hpi
total
rna
extract
trizol
rtpcr
perform
amplifi
region
encod
gene
prrsv
n
gene
pedv
use
genespecif
primer
set
tabl
correspond
pcr
product
clone
pgemt
vector
promega
madison
wi
sequenc
gene
recombin
vector
select
independ
bacteri
coloni
per
group
analyz
mutat
region
student
test
use
statist
analys
pvalu
less
consid
statist
signific
virusspecif
cpe
observ
daili
photograph
hpi
use
invert
microscop
magnif
first
panel
immunostain
infect
cell
fix
hpi
incub
mab
n
protein
prrsv
pedv
follow
alexa
greenconjug
goat
antimous
secondari
antibodi
second
panel
cell
counterstain
dapi
third
panel
examin
use
fluoresc
microscop
magnif
viral
product
presenc
ribavirin
measur
quantifi
number
cell
express
n
protein
ifa
five
field
magnif
count
per
condit
total
number
cell
per
field
determin
dapi
stain
similar
field
valu
repres
mean
three
independ
experi
error
bar
repres
standard
deviat
p
p
examin
effect
ribavirin
porcin
nidoviru
replic
prrsv
pedv
select
import
viral
pathogen
econom
affect
swine
industri
base
mtt
assay
none
dose
ribavirin
test
present
studi
caus
detect
cell
death
vero
cell
data
shown
vero
cell
pretreat
ribavirin
concentr
respect
dw
vehicl
control
h
prior
infect
ribavirin
present
entir
period
infect
viral
product
initi
measur
monitor
cytopath
effect
cpe
infect
confirm
immunofluoresc
use
n
proteinspecif
mab
hpi
fig
vehicletr
control
cell
visibl
cpe
appear
hpi
becam
predomin
hpi
nspecif
stain
clearli
evid
mani
cell
cluster
indic
infect
spread
viru
neighbor
cell
contrast
ribavirin
obviou
inhibitori
effect
viru
propag
shown
fig
b
ribavirin
significantli
decreas
virusinduc
cpe
viral
gene
express
prrsv
pedv
concentr
respect
n
protein
stain
reveal
number
cell
express
viral
antigen
quantifi
n
protein
stain
result
also
reduc
ribavirin
treatment
result
maximum
inhibit
respons
prrsv
pedv
respect
fig
b
moreov
effect
dose
inhibit
ed
replic
prrsv
pedv
determin
respect
taken
togeth
data
demonstr
ribavirin
effici
suppress
replic
porcin
nidovirus
determin
point
ribavirin
act
porcin
nidoviru
infect
period
vero
cell
treat
independ
ribavirin
variou
time
point
postinfect
hpi
level
prrsv
pedv
replic
measur
indirectli
viral
antigen
product
quantifi
cell
express
n
protein
ifa
fig
treatment
cell
ribavirin
hpi
result
decreas
prrsv
product
compar
untreat
control
addit
ribavirin
hpi
led
inhibit
prrsv
infect
similarli
treatment
ribavirin
hpi
found
lead
suppress
pedv
product
treatment
hpi
result
reduct
pedv
infect
contrast
signific
impair
porcin
nidoviru
propag
observ
ribavirin
ad
hpi
result
demonstr
inhibitori
effect
ribavirin
replic
prrsv
pedv
exert
primarili
initi
period
infect
suggest
action
occur
mainli
earli
time
point
porcin
nidoviru
infect
assess
antivir
activ
ribavirin
porcin
nidoviru
replic
viru
yield
determin
treatment
ribavirin
upon
infect
viral
supernat
collect
hpi
viral
titer
measur
fig
show
presenc
ribavirin
reduc
releas
viral
progeni
dosedepend
manner
peak
viral
titer
determin
tcid
ml
pfuml
vehicletr
control
prrsv
pedv
respect
howev
addit
ribavirin
decreas
titer
prrsv
pedv
tcid
ml
pfuml
respect
almost
log
reduct
compar
control
growth
kinet
studi
demonstr
overal
process
porcin
nidoviru
replic
significantli
delay
cell
treat
ribavirin
fig
consequ
find
reveal
ribavirin
inhibit
optim
progeni
viru
releas
within
natur
host
cell
evalu
step
replic
cycl
porcin
nidovirus
target
ribavirin
start
focus
earliest
step
viru
entri
upon
ribavirin
treatment
address
issu
intern
assay
perform
describ
previous
cai
et
al
vero
cell
inocul
prrsv
pedv
respect
c
h
allow
viru
attach
maintain
either
c
c
permit
viru
intern
presenc
ribavirin
sampl
treat
proteas
k
remov
remain
virus
cell
surfac
serial
dilut
infect
cell
subsequ
subject
infecti
center
assay
uninfect
vero
cell
monolay
viru
titer
measur
day
later
ifa
plaqu
assay
shown
fig
titer
prrsv
pedv
virtual
cell
treat
ribavirin
without
ribavirin
c
determin
tcid
ml
pfuml
respect
indic
differ
cell
contrast
minim
viral
product
tcid
ml
prrsv
pfuml
pedv
observ
cell
maintain
c
like
due
ineffici
remov
bound
viru
result
indic
ribavirin
inhibitori
effect
viru
entri
process
like
positivesens
rna
virus
follow
uncoat
process
nidoviru
genom
releas
cytoplasm
immedi
serv
templat
viral
translat
cellular
capdepend
mechan
earli
nidoviru
translat
produc
replicas
polyprotein
posttransl
cleav
nsp
viral
proteas
subsequ
nonstructur
replicas
protein
mediat
de
novo
synthesi
viral
rna
includ
genom
rna
replic
sg
mrna
transcript
nidoviru
structur
protein
translat
late
respect
sg
mrna
transcript
thu
determin
inhibitori
mechan
ribavirin
postentri
step
nidoviru
life
cycl
first
investig
whether
viral
protein
translat
affect
ribavirin
accomplish
vero
cell
treat
ribavirin
h
prior
infect
drug
allow
remain
infect
subsequ
incub
express
level
prrsv
n
pedv
protein
presenc
absenc
ribavirin
evalu
hpi
western
blot
analysi
product
protein
product
drastic
diminish
ribavirin
treatment
fig
densitometr
analysi
western
blot
reveal
intracellular
express
n
protein
reduc
ribavirin
maximum
inhibit
concentr
respect
fig
mark
reduct
probabl
result
nonspecif
decreas
translat
mechan
sinc
ponceau
stain
result
indirectli
indic
express
level
overal
cellular
protein
remain
similar
follow
treatment
data
shown
taken
togeth
result
demonstr
inhibitori
effect
ribavirin
specif
viral
translat
porcin
nidoviru
replic
positivestrand
rna
virus
synthesi
viral
nonstructur
protein
requir
viral
rna
replic
transcript
thu
conceiv
impair
viral
protein
express
would
caus
inhibit
viral
rna
synthesi
sinc
nidoviru
infect
produc
two
rna
entiti
includ
genom
versu
subgenom
therefor
determin
ribavirin
specif
affect
genom
replic
sg
mrna
transcript
answer
question
rel
level
genom
rna
sg
mrna
assess
quantit
realtim
strandspecif
rtpcr
presenc
absenc
ribavirin
upon
porcin
nidoviru
infect
shown
fig
ribavirin
exhibit
maxim
reduct
synthesi
prrsv
genom
rna
sg
wash
cold
pb
infect
cell
maintain
presenc
absenc
ribavirin
either
c
c
addit
hour
bound
unintern
viru
particl
remov
treatment
proteas
k
infect
cell
serial
dilut
plate
onto
fresh
target
cell
day
postincub
intern
virus
titrat
ifa
plaqu
assay
prrsv
left
pedv
right
respect
result
express
mean
valu
triplic
well
error
bar
repres
standard
deviat
p
p
mrna
concentr
respect
compar
untreat
infect
cell
furthermor
similar
inhibitori
effect
ribavirin
genom
replic
sg
mrna
transcript
pedv
observ
amount
pedv
genom
rna
sg
mrna
detect
cell
treat
ribavirin
untreat
level
fig
decreas
viral
rna
level
addit
ribavirin
due
nonspecif
inhibit
transcript
mrna
level
intern
control
gapdh
remain
unchang
sampl
data
shown
altogeth
result
indic
ribavirin
suppress
synthesi
nidovir
genom
rna
sg
mrna
sever
mechan
action
antivir
activ
ribavirin
suggest
includ
reduct
cellular
gtp
pool
via
inosin
monophosph
dehydrogenas
impdh
inhibit
increas
mutat
frequenc
viru
genom
lead
error
catastroph
graci
cameron
assess
known
mechan
first
examin
whether
replenish
guanosin
affect
antivir
effect
ribavirin
porcin
nidoviru
infect
addit
guanosin
ribavirintr
virusinfect
cell
found
moder
revers
antivir
activ
ribavirin
incub
ribavirin
alon
reduc
prrsv
product
respect
wherea
supplement
guanosin
ribavirin
inhibit
viru
product
concentr
fig
left
panel
likewis
pedv
product
declin
presenc
ribavirin
alon
respect
decreas
concentr
guanosin
ad
ribavirin
treatment
fig
right
panel
verifi
result
also
test
effect
mpa
potent
inhibitor
cellular
impdh
replic
prrsv
pedv
shown
fig
mpa
effici
reduc
porcin
nidoviru
propag
fig
inhibit
viral
protein
translat
ribavirin
ribavirintr
vero
cell
mockinfect
infect
prrsv
pedv
b
h
cultiv
presenc
absenc
ribavirin
hpi
cellular
lysat
collect
resolv
sdspage
transfer
nitrocellulos
membran
immunoblot
use
antibodi
recogn
prrsv
n
protein
pedv
protein
blot
also
react
mous
mab
verifi
equal
protein
load
viral
protein
express
quantit
analyz
densitometri
term
rel
densiti
valu
gene
ribavirintr
sampl
result
compar
vehiclecontrol
result
valu
repres
mean
three
independ
experi
error
bar
denot
standard
deviat
p
p
inhibit
viral
rna
transcript
ribavirin
vero
cell
pretreat
ribavirin
mockinfect
infect
prrsv
pedv
b
h
incub
presenc
ribavirin
total
cellular
rna
extract
hpi
strandspecif
viral
genom
rna
black
bar
sg
mrna
white
bar
prrsv
pedv
amplifi
quantit
realtim
rtpcr
viral
positivesens
genom
rna
sg
mrna
normal
mrna
porcin
monkey
gapdh
rel
quantiti
rq
mrna
accumul
evalu
ribavirintr
sampl
result
compar
untreat
result
valu
repres
mean
three
independ
experi
error
bar
denot
standard
deviat
p
p
concentr
greater
dosedepend
manner
prrsv
pedv
respect
sequenc
analysi
porcin
nidoviru
genom
presenc
absenc
ribavirin
conduct
investig
whether
trigger
catastroph
mutat
analyz
recombin
sequenc
region
correspond
nucleotid
number
prrsv
n
gene
region
correspond
nucleotid
number
pedv
viru
grown
presenc
ribavirin
control
coloni
also
obtain
individu
untreat
prrsvand
pedvinfect
prrsv
code
region
bp
pedv
n
bp
gene
rtpcr
amplifi
amplicon
product
clone
pgemt
vector
sequenc
gene
recombin
vector
clone
per
group
select
analyz
number
rate
mutat
b
total
nt
nt
prrsv
pedv
sequenc
mutat
frequenc
calcul
per
nt
respect
cell
ribavirintr
group
point
mutat
occur
plasmid
prrsv
pedv
correspond
mutat
frequenc
per
nt
respect
interestingli
mutat
also
found
plasmid
untreat
group
prrsv
pedv
calcul
mutat
frequenc
per
nt
respect
tabl
sequenc
result
indic
signific
differ
mutat
rate
ribavirintr
nontreat
group
upon
porcin
nidoviru
infect
nidoviral
order
envelop
positivestrand
rna
virus
anim
host
synthes
nest
set
multipl
sg
mrna
order
includ
three
famili
arterivirida
coronavirida
ronivirida
similar
genom
organ
replic
strategi
differ
virion
morpholog
genom
length
mayo
lai
et
al
snijder
spaan
porcin
nidovirus
devast
viral
pathogen
pig
popul
also
appli
anim
viru
model
studi
human
veterinaryimport
nidovirus
among
despit
tremend
effort
control
diseas
prrsv
pedv
continu
plagu
pigproduc
countri
lead
signific
econom
impact
global
asian
swine
industri
respect
partial
due
lack
effici
vaccin
capabl
confer
full
protect
viral
infect
antivir
agent
treat
porcin
nidovirus
although
ribavirin
antivir
effect
varieti
dna
rna
virus
sidwel
et
al
efficaci
mode
action
porcin
nidoviru
replic
current
unknown
present
studi
demonstr
ribavirin
also
exert
effect
antivir
activ
prrsv
pedv
vitro
indic
ed
valu
approxim
gml
gml
respect
ribavirin
potenti
act
via
inhibit
variou
step
viru
life
cycl
includ
viral
translat
genom
transcript
cap
rna
synthesi
progeni
viru
spread
graci
cameron
treatment
cell
ribavirin
result
signific
attenu
postentri
step
replic
porcin
nidoviru
determin
lower
progeni
product
diminish
viral
protein
express
decreas
synthesi
genom
rna
sg
mrna
previous
report
tier
murin
noroviru
presenc
ribavirin
drop
viru
infect
remain
similar
h
viru
infect
chang
georg
studi
growth
kinet
experi
also
indic
reduc
rate
nidovir
titer
presenc
ribavirin
found
compar
hpi
sinc
ribavirin
convert
monophosph
activ
form
rmp
exert
antivir
activ
appear
viru
infect
may
disrupt
normal
metabol
process
lead
interfer
convers
ribavirin
parker
taken
togeth
data
indic
ribavirin
potent
elicit
antivir
activ
prrsv
pedv
target
cell
import
aspect
antivir
activ
ribavirin
may
attribut
abil
act
via
multipl
mechan
simultan
although
mechan
action
ribavirin
still
remain
controversi
five
primari
mechan
propos
depend
particular
viru
includ
reduct
cellular
gtp
pool
inhibit
impdh
enhanc
mutat
frequenc
via
incorpor
viral
genom
lead
catastroph
error
modul
host
immun
respons
inhibit
mrna
cap
interfer
viral
rna
polymeras
therefor
mechan
action
ribavirin
may
differ
among
virus
antivir
activ
may
oper
predominantli
via
one
two
mechan
graci
cameron
parker
elucid
potenti
mechan
respons
antivir
effect
ribavirin
porcin
nidovirus
first
test
whether
antinidovir
activ
ribavirin
involv
inhibit
impdh
subsequ
depress
cellular
gtp
level
previou
studi
addit
guanosin
cultur
medium
effici
revers
antivir
effect
ribavirin
noroviru
yellow
fever
viru
human
parainfluenza
viru
chang
georg
leyssen
et
al
present
studi
investig
effect
replenish
gtp
ad
guanosin
ribavirintr
cell
upon
viru
infect
consist
previou
report
addit
guanosin
ribavirin
treatment
significantli
revers
antivir
activ
ribavirin
porcin
nidovirus
furthermor
noncompetit
impdh
inhibitor
mpa
found
strongli
inhibit
replic
prrsv
pedv
concentr
respect
contrast
ribavirin
convert
activ
rmp
form
elicit
antivir
activ
mpa
requir
metabol
activ
exert
function
thu
effici
antinidovir
activ
mpa
suggest
ribavirin
may
directli
lead
inhibit
intracellular
impdh
level
sinc
rna
virus
replic
high
genet
variat
exist
viral
quasispeci
complex
dynam
mutant
distribut
share
domin
nucleotid
sequenc
mutant
spectrum
ruizjarabo
et
al
therefor
rna
virus
resid
edg
mutat
crisi
increas
averag
error
frequenc
caus
defect
genet
inform
reduc
viabil
term
error
catastroph
crotti
et
al
day
et
al
ribavirin
shown
trigger
catastroph
mutat
includ
lethal
mutat
varieti
virus
may
accumul
viru
goe
multipl
round
replic
result
extinct
viral
popul
crotti
et
al
contrera
et
al
day
et
al
lanford
et
al
severson
et
al
howev
sequenc
analysi
conserv
n
gene
region
prrsv
pedv
ribavirintr
untreat
group
reveal
two
group
produc
similar
mutat
frequenc
versu
result
surpris
sinc
rna
genom
mutat
averag
rate
per
nucleotid
copi
replic
rna
virus
virusencod
rnadepend
rna
polymeras
rdrp
lack
proofread
function
drake
holland
data
indic
antivir
activ
ribavirin
porcin
nidovirus
may
associ
errorpron
replic
increas
probabl
ribavirin
incorpor
viral
genom
conclus
find
describ
demonstr
ribavirin
effect
prevent
replic
porcin
nidovirus
target
cell
subcytotox
dose
addit
highest
dose
ribavirin
use
studi
increas
frequenc
mutat
nidovir
genom
instead
affect
intracellular
gtp
level
via
impdh
inhibit
thu
propos
one
mode
action
ribavirin
elicit
antivir
effect
porcin
nidovirus
occur
via
gtp
deplet
may
work
concert
catastroph
mutat
although
studi
base
vivo
assess
need
evalu
efficaci
safeti
ribavirin
result
present
indic
good
candid
choic
antivir
approach
porcin
nidovir
diseas
